Evidence map›Paper›PMID 33851776›Full record

ArticleEMBO molecular medicine2021

Neurodegenerative VPS41 variants inhibit HOPS function and mTORC1-dependent TFEB/TFE3 regulation.

Reini E N van der Welle, Rebekah Jobling, Christian Burns, Paolo Sanza, Jan A van der Beek, Alfonso Fasano, Lan Chen, Fried J Zwartkruis, Susan Zwakenberg, Edward F Griffin and 16 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 53 citations in OpenAlex.

  1. Ion transport as a determinant of membrane fusion and fission.Nature structural & molecular biology · 2026
    Review
  2. Article
  3. Article
  4. NPC1 trafficking via VPS41-dependent LAMP carriers regulates endosomal cholesterol homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Integrated regulation of dopaminergic and epigenetic effectors of neuroprotection in Parkinson's disease models.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 7 institutions in 3 countries.

Reini E N van der WelleSection Cell Biology, Center for Molecular Medicine, Institute of Biomembranes, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0002-5591-2846
Rebekah JoblingDepartment of Pediatrics, Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Christian BurnsDepartment of Biological Sciences, Division of Natural Sciences and Mathematics, University of Denver, Denver, CO, USA.
Paolo SanzaSection Cell Biology, Center for Molecular Medicine, Institute of Biomembranes, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Jan A van der BeekSection Cell Biology, Center for Molecular Medicine, Institute of Biomembranes, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0003-4957-9175
Alfonso FasanoEdmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, ON, Canada.
Lan ChenDepartment of Biological Sciences, Division of Natural Sciences and Mathematics, University of Denver, Denver, CO, USA.
Fried J ZwartkruisSection Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0001-5775-1313
Susan ZwakenbergSection Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Edward F GriffinDepartment of Biological Sciences, The University of Alabama, Tuscaloosa, AL, USA.
Corlinda Ten BrinkSection Cell Biology, Center for Molecular Medicine, Institute of Biomembranes, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Tineke VeenendaalSection Cell Biology, Center for Molecular Medicine, Institute of Biomembranes, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Nalan LivSection Cell Biology, Center for Molecular Medicine, Institute of Biomembranes, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Conny M A van Ravenswaaij-ArtsDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Henny H LemminkDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-2748-803X
Rolph PfundtDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Susan BlaserDepartment of Diagnostic Imaging, Hospital for Sick Children, Toronto, ON, Canada.
Carolina SepulvedaEdmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, ON, Canada.
Andres M LozanoKrembil Brain Institute, Toronto, ON, Canada.
Grace YoonDepartment of Pediatrics, Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Teresa Santiago-SimGeneDx, Inc, Gaithersburg, MD, USA.
Cedric S AsensioDepartment of Biological Sciences, Division of Natural Sciences and Mathematics, University of Denver, Denver, CO, USA.ORCID 0000-0002-2284-0217
Guy A CaldwellDepartment of Biological Sciences, The University of Alabama, Tuscaloosa, AL, USA.ORCID 0000-0002-8283-9090
Kim A CaldwellDepartment of Biological Sciences, The University of Alabama, Tuscaloosa, AL, USA.ORCID 0000-0003-1580-6122
David ChitayatDepartment of Pediatrics, Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.ORCID 0000-0003-1944-7294
Judith KlumpermanSection Cell Biology, Center for Molecular Medicine, Institute of Biomembranes, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0003-4835-6228
Utrecht University · NLUniversity of Toronto · CAUniversity of Alabama · USUniversity of Denver · USUniversity Medical Center Groningen · NLHospital for Sick Children · CARadboud University Nijmegen · NL

Funding

Formation of the Regulated Secretory Pathway: a View from the CytosolR01GM124035 · NIGMS · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI ASENSIO, CEDRIC STEPHANE · 2017 to 2021
$1.5M
Investigating Neuroprotective Targets for Parkinson Disease Associated with AutopR15NS075684 · NINDS · UNIVERSITY OF ALABAMA IN TUSCALOOSA · PI CALDWELL, GUY A · 2011 to 2011
$411k
Cellular Mechanisms Controlling the Formation of Large Dense Core VesiclesR15GM116096 · NIGMS · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI ASENSIO, CEDRIC STEPHANE · 2015 to 2015
$360k
NIGMS NIH HHS R01 GM124035NIGMS NIH HHS R15 GM116096NINDS NIH HHS R15 NS075684
6 · The paper itself

Abstract

Vacuolar protein sorting 41 (VPS41) is as part of the Homotypic fusion and Protein Sorting (HOPS) complex required for lysosomal fusion events and, independent of HOPS, for regulated secretion. Here, we report three patients with compound heterozygous mutations in VPS41 (VPS41

Indexed as

Neurodegenerative DiseasesAnimalsAutophagyBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCaenorhabditis elegansHeLa CellsHumansLysosomesMechanistic Target of Rapamycin Complex 1Protein TransportVesicular Transport ProteinsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsMechanistic Target of Rapamycin Complex 1TFE3 protein, humanTFEB protein, humanVesicular Transport ProteinsVPS41 protein, humanAutophagyHOPS complexlysosome-associated disordermTORC1TFEB/TFE3

Identifiers

PMID33851776
PMCPMC8103106
OpenAlexW3152529170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.